Comprehensive Analysis of RELL2 as a Potential Biomarker Associated with Tumor Immune Infiltrating Cells in a Pan-Cancer Analysis
Open Access
- 18 May 2022
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2022, 1-21
Abstract
Background. Receptor expressed in lymphoid tissues-like 2 (RELL2), which is a member of RELT family, is closely associated with the plasma membrane and acts as a modulator for RELT signaling. Overexpression of RELL2 induces the activation of MAPK14/p38 cascade and apoptosis. However, whether RELL2 contributes to cancers remains unclear. Here, we examined its role in cancer patient prognosis and various tumors. Methods. We used several bioinformatics methods, specifically gene set enrichment analysis (GSEA), ScanNeo, and ESTIMATE, to analyze the CCLE dataset, GTEx dataset, and TCGA dataset. We investigated the possible association of RELL2 with the microsatellite instability (MSI) of various tumors, tumor mutational burden (TMB), immune checkpoint, immune neoantigens, immune microenvironment, and patient prognosis. Result. RELL2 is highly expressed in cancer compared with normal tissues. RELL2 expression is linked with worse progression-free interval and overall survival in numerous cancers. In most cancers, high RELL2 expression was related to a poor prognosis. RELL2 expression was significantly associated with the tumor microenvironment, MSI, and TMB. RELL2 expression is strongly associated with phenotypes that are of major clinical significance, particularly those associated with immune neoantigens and the expression profiles of immune checkpoint genes in pan-cancer. RELL2 expression strongly linked with the expressions of methyltransferases and DNA repair genes. It also significantly correlated with multiple signaling pathways through gene set enrichment analysis. Conclusion. RELL2 may be a prognostic biomarker in pan-cancer and may have an important function in tumorigenesis and progression.Keywords
Funding Information
- Nanjing Medical University (ZM201803, ZDRCA2016051, BE2018673, 81902334, 81874067)
- Health Commission of Jiangsu Province (ZM201803, ZDRCA2016051, BE2018673, 81902334, 81874067)
- Science and Technology Bureau of Jiangsu Province (ZM201803, ZDRCA2016051, BE2018673, 81902334, 81874067)
- National Natural Science Foundation of China (ZM201803, ZDRCA2016051, BE2018673, 81902334, 81874067)
This publication has 44 references indexed in Scilit:
- Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells ProliferationPLOS ONE, 2012
- Exploring Protein Lipidation with Chemical BiologyChemical Reviews, 2011
- The role of inflammation in epilepsyNature Reviews Neurology, 2010
- Stage-specific sensitivity to p53 restoration during lung cancer progressionNature, 2010
- Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell lineChemico-Biological Interactions, 2010
- Clinical Relevance of Microsatellite Instability in Colorectal CancerJournal of Clinical Oncology, 2010
- Chromatin structure and the inheritance of epigenetic informationNature Reviews Genetics, 2010
- Leukaemogenesis: more than mutant genesNature Reviews Cancer, 2010
- RELT induces cellular death in HEK 293 epithelial cellsCellular Immunology, 2010
- Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinomaCarcinogenesis, 2006